None listed
Conditions
Interventions
Medical Device, Procedure/Surgery : (1) Subjects who have agreed to participate in the trial are assigned 1:1 into the control group and the test group through randomization.
? Control group: 13 pat
Sponsors
Hanyang University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1) Patients 19 years of age or older who are expected to undergo cesarean section * Surgical range: patient within 15cm X 10cm 2) A person who understands the purpose of this clinical trial and is willing to comply with the clinical trial protocol with a voluntary decision to participate
Exclusion criteria
Exclusion criteria: 1) Those with gestational diabetes 2) Those with comorbidities that may affect wound healing (malignant tumors, vasculitis, connective tissue disease) 3) Patients with clinical infection, those who are immunosuppressed 4) Those who are taking treatment (drugs, ointments, etc.) that may affect wound healing (e.g. steroids, aspirin, etc.) 5) Others judged by the investigator as unsuitable to participate in the clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bluebelle Wound Healing Questionnaire(Bluebelle WHQ) assessment | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS(10cm Visual Analog Scale) assessment;Confirmation of exudate, re-epithelialization, and proliferation of granulation tissue at the surgical wound site in control group and test group;The number of days it took for the wound at the cesarean section to heal (wound healing period);Overall satisfaction of participants regarding the Investigational medical device;Adverse events / Serious adverse events | — |
Countries
Korea, Republic of
Contacts
Public ContactKi-Young Ryu
Hanyang University
Outcome results
None listed